Biomarin Pharmaceutical Inc (BMRN)

Net profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	167,645	141,561	-64,080	854,029	-23,848
Revenue	US$ in thousands	2,374,190	2,068,670	1,832,750	1,823,140	1,680,280
Net profit margin		7.06%	6.84%	-3.50%	46.84%	-1.42%

December 31, 2023 calculation

Net profit margin = Net income ÷ Revenue
= $167,645K ÷ $2,374,190K
= 7.06%

Over the past five years, Biomarin Pharmaceutical Inc's net profit margin has exhibited fluctuations. The net profit margin was negative in 2021 and 2019, indicating that the company incurred net losses during those years. However, the company saw significant improvements in profitability in 2020 and 2023, with net profit margins of 46.84% and 7.06% respectively. The net profit margin provides insight into the company's ability to generate profit from its revenue, with a higher percentage indicating better efficiency in converting sales into profit. It is important for investors and stakeholders to monitor this metric as it reflects the company's overall financial health and performance.